Korea Ever-Power · BXG Series · Pharmaceutical GMP Drive Guide

21 CFR 211.65 requires that equipment surfaces that contact components, drug product in-process materials, or drug products are not reactive, additive, or absorptive so as to alter safety, identity, strength, quality, or purity beyond established requirements. 21 CFR 211.67 requires that equipment is cleaned and maintained at appropriate intervals. A motor with a corroded or rough surface above a pharmaceutical processing vessel fails the 211.65 requirement because surface particles or corrosion products can contaminate the drug substance below.

EU GMP Annex 2 (2020 revision) for biological medicines requires that equipment used in the manufacturing of biological APIs and drug products is designed and constructed to facilitate cleaning and sterilisation. All surfaces in contact with or in proximity to the product must be smooth, free from crevices and corners, easily cleaned, and resistant to the cleaning and sterilisation agents used. Motors installed in Grade C and Grade D cleanroom areas must comply with these material and surface requirements.

EU GMP Annex 1 (2022 revision) for sterile medicinal products applies the highest equipment hygiene standards to Grade A/B cleanrooms (aseptic filling areas). Equipment in Grade A and B areas must be designed for sterilisation-in-place (SIP) and cleaning-in-place (CIP), with smooth, non-shedding surfaces resistant to autoclave sterilisation temperatures and all cleaning agents used. Motors in these areas must be specifically qualified as part of the cleanroom design. Contact Korea Ever-Power for BXG specifications for Grade A/B environments.

Standard pharmaceutical GMP cleaning uses purified water (PW) or water for injection (WFI) as the solvent with alkaline detergents (NaOH 0.5 to 2%, pH 11 to 13) and acid rinses (phosphoric acid or citric acid 0.5 to 1%). The BXG SS316L resists these agents fully. Motor cleaning is performed by manual wiping or spray with cleaned cloths wetted with PW/WFI — the IP69K certification confirms resistance to pressurised spray cleaning.

Pharmaceutical cleanrooms use 70% isopropyl alcohol (IPA) or 70% ethanol spray for surface disinfection between production batches. The BXG SS316L motor surface is fully resistant to IPA and ethanol at these concentrations. The FDA silicone shaft seals and NSF H1 bearing grease are also compatible with alcohol disinfection at pharmaceutical use concentrations. Spray IPA disinfection does not compromise the BXG IP69K integrity.

Vaporised hydrogen peroxide (VHP) at concentrations of 150 to 750 ppm H₂O₂ is used for Grade A/B cleanroom decontamination cycles following maintenance or at product changeover. VHP is compatible with SS316L and all BXG seal and grease materials at pharmaceutical sterilisation concentrations. For Grade A/B motor applications requiring VHP exposure, confirm motor documentation and material certificates with Korea Ever-Power.

EU GMP and FDA guidance both reference the EHEDG surface roughness standard of Ra ≤ 0.8 μm as the threshold for effective cleanability. Below this roughness, bacterial adhesion and biofilm formation are significantly reduced and surface cleaning with standard detergents achieves the microbial reduction required for pharmaceutical GMP. The BXG motor is finished to Ra ≤ 0.8 μm on all external surfaces as delivered, and the SS316L material does not roughen under normal GMP cleaning cycles. Verify surface finish at IQ stage and re-verify at periodic requalification intervals as defined in the site change control procedure.

GMP requires elimination of areas on motor surfaces where product, cleaning solution, or microbial contamination could accumulate without being reached by cleaning procedures. The BXG frame is designed with angled cooling fins that drain freely, a convex terminal box lid (no flat horizontal surface), smooth welded construction rather than mechanically joined panels, and smooth socket-cap fasteners rather than cross-head or hex-socket fasteners that create particle entrapment points. These design features are documented in the BXG technical file for inclusion in the GMP equipment qualification.

Motor model and serial number; manufacturer certificate of conformity; material certificate for SS316L frame (EN 10204 Type 3.1 material test certificate); surface roughness measurement report (Ra ≤ 0.8 μm); IP69K test certificate; FDA 21 CFR material compliance statements for seals and grease; NSF H1 certificate for bearing grease.

Motor rated speed, torque, and power at installation; vibration signature at commissioning; motor protection relay setting record; cleaning procedure qualification for the motor installed in its specific position; cleaning agent compatibility confirmation; first post-installation inspection record.

PQ confirms the motor performs correctly as part of the production equipment during commercial manufacturing. Requalification is triggered by change control events: motor replacement, motor repair, cleaning agent change, or facility reconfiguration. Korea Ever-Power provides all necessary IQ documentation with each BXG order to pharmaceutical customers.

The Korea Ever-Power BXG series is the complete motor specification for Grade B, C, and D pharmaceutical GMP manufacturing areas. It combines IP69K washdown protection with SS316L acid and alkali resistant construction, Ra ≤ 0.8 μm hygienic surface finish, FDA silicone shaft seals, NSF H1 pharmaceutical-grade bearing grease, and Class H insulation. The BXG technical file includes all documentation required for pharmaceutical equipment IQ. The complete range is in the stainless steel motor product section. For Grade A/B sterile manufacturing environment specifications or pharmaceutical validation support, contact the Korea Ever-Power technical team.

Tablet coating pans in Grade C rooms rotate at 3 to 25 rpm for tablet bed tumbling. BXG 0.75 to 2.2 kW 4-pole with NMRV gearbox at 40:1 to 100:1. Pan interior is in direct contact with pharmaceutical product. The BXG motor on the pan exterior must be cleanable with the same agents used to clean the pan interior.

External agitator drive motors on bioreactors and fermentation vessels in Grade C biological manufacturing. BXG 0.37 to 2.2 kW at 20:1 to 60:1 NMRV gearmotor. The motor is external to the vessel but within the Grade C boundary; daily cleaning with IPA and weekly cleaning with caustic solution is typical. BXG SS316L and FDA silicone seals withstand this cleaning regime without degradation.

Automated vial loading and unloading systems for freeze-dryers (lyophilisers) in Grade B areas adjacent to Grade A aseptic fill. BXG 0.18 to 0.75 kW for vial transport conveyor drives. The lyophiliser loading area is Grade B during loading operations; BXG VHP compatibility confirmed for GMP decontamination cycles.

Water for injection (WFI) distribution loop pump drives in pharmaceutical water systems. The motor is typically located outside the GMP room in a utility area but may be subject to WFI spray during maintenance. BXG 0.75 to 3.0 kW, 2-pole for WFI pump drives requiring corrosion resistance to high-purity water and steam cleaning of the pump room.